Elevance Health director granted 563 stock units

DeVore Susan D. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

DeVore Susan D. reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health director Susan D. DeVore received an award of 563 deferred stock units of common stock on May 13. The grant was made at no cash cost as part of the company’s Board of Directors Compensation Program and increases her direct holdings to 4,065 shares-equivalent.

The deferred stock units will be settled in Elevance Health common stock upon the earlier of five years from the grant date or when she leaves the board, unless she has elected a later payment date under the Board of Directors Deferred Compensation Plan.

Insider Trade Summary

Grant/Award: 563 shares

Grant/Award 1 txn

Insider DeVore Susan D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	$0.00

Holdings After Transaction: Common Stock — 4,065 shares (Direct)

Footnotes (2)

1. F1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. F2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock units granted: 563 units Grant price per unit: $0.0000 Holdings after transaction: 4,065 shares-equivalent

3 metrics

Deferred stock units granted 563 units Grant on May 13 under Board Compensation Program

Grant price per unit $0.0000 Non-cash director compensation award

Holdings after transaction 4,065 shares-equivalent Total Elevance Health common stock after grant

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan

3 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elevance Health (ELV) director Susan D. DeVore report in this Form 4?

Susan D. DeVore reported receiving 563 deferred stock units of Elevance Health common stock. The award was granted at no cash cost as director compensation and increased her direct holdings to 4,065 shares-equivalent after the transaction.

How many Elevance Health (ELV) shares does Susan D. DeVore hold after this grant?

After the grant, Susan D. DeVore holds 4,065 shares-equivalent of Elevance Health common stock. This total includes the newly awarded 563 deferred stock units reported in the Form 4 as part of the company’s director compensation arrangements.

Was cash paid for the 563 Elevance Health (ELV) deferred stock units granted?

No cash was paid for the 563 deferred stock units; the reported price per share is 0.0000. The filing describes the award as deferred stock units accrued under Elevance Health’s Board of Directors Compensation Program, reflecting non-cash director compensation.

When will Susan D. DeVore receive Elevance Health (ELV) shares for these deferred stock units?

The deferred stock units will be paid in Elevance Health common stock at the earlier of five years from the grant date or when she ceases to be a board member, unless she designated a later date under the Board of Directors Deferred Compensation Plan.

Is this Elevance Health (ELV) Form 4 a market purchase or sale of shares?

This Form 4 does not show a market purchase or sale. It reports a grant of 563 deferred stock units as director compensation, coded as an acquisition (transaction code A) with a zero cash price, rather than an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeVore Susan D.

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	4,065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)